This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The document provides an overview of malaria in the Americas, describing its transmission, symptoms, vulnerable populations, and regional trends, while highlighting prevention strategies and the efforts of PAHO/WHO and member states to eliminate the disease by 2020.